Generic drugs, cheaper than their brand-name counterparts, are crucial to reducing the high cost of prescription medicines for many patients. Though generics make up 89% of prescriptions , barriers exist to their market entry such as delays from practices like ‘evergreening’ and ‘pay-for-delay’ agreements. Policymakers could help by implementing strategies to reduce these barriers, speeding up review processes, promoting transparency, and encouraging more competition. This would help provide access to affordable and effective therapies for all.
Malware Defense 101 – Identifying and Removing Modern Threats
Cybersecurity threats in 2025 have become more sophisticated, with malware leveraging AI, evasion tactics, and polymorphic code. Data-stealing malware dominates, increasing by 180% in 2024.
